Loading…

Incidence of polyomavirus‐nephropathy in renal allografts: influence of modern immunosuppressive drugs

Background. In recent years an increasing number of cases with polyomavirus (PV)‐nephropathy after renal transplantation were reported from several transplant centres. New, highly potent immunosuppressive drugs like tacrolimus or mycophenolate mofetil were accused as risk factors for this increase....

Full description

Saved in:
Bibliographic Details
Published in:Nephrology, dialysis, transplantation dialysis, transplantation, 2003-06, Vol.18 (6), p.1190-1196
Main Authors: Mengel, Michael, Marwedel, Magali, Radermacher, Jörg, Eden, Gabriele, Schwarz, Anke, Haller, Hermann, Kreipe, Hans
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background. In recent years an increasing number of cases with polyomavirus (PV)‐nephropathy after renal transplantation were reported from several transplant centres. New, highly potent immunosuppressive drugs like tacrolimus or mycophenolate mofetil were accused as risk factors for this increase. However, data about the incidence of PV‐nephropathy in correlation to different immunosuppressive therapy concepts are lacking. Methods. All renal transplant biopsies performed at Hannover Medical School between 1999 and 2001 (n=1276) were immunohistochemically screened for the presence of PV‐specific proteins. The results were correlated to the different immunosuppressive therapy protocols and patients with PV‐nephropathy were compared with a matched control group. Results. PV‐nephropathy was found in
ISSN:0931-0509
1460-2385
DOI:10.1093/ndt/gfg072